Raxibacumab
NDC Package 49401-103-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Raxibacumab is a . Marketed by Human Genome Sciences, Inc., this product is identified by NDC 49401-103 and is authorized under FDA application BLA125349.

Identification & Billing

NDC Package Code
49401-103-01
Package Description
1 VIAL, SINGLE-USE in 1 CARTON / 34 mL in 1 VIAL, SINGLE-USE
Product Code
49401-103
11-Digit Billing Format
49401010301

Clinical Specifications

Proprietary Name
Raxibacumab
Dosage Form
-

Regulatory & Marketing

Labeler Name
Human Genome Sciences, Inc.
FDA Application #
BLA125349
Marketing Category
BLA - A product marketed under an approved Biologic License Application.
Start Marketing Date
12-14-2012
End Marketing Date
05-31-2022
Listing Expiration
05-31-2022
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 49401-103-01 identifies a specific commercial package of 1 vial, single-use in 1 carton / 34 ml in 1 vial, single-use of Raxibacumab, labeled by Human Genome Sciences, Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Human Genome Sciences, Inc. on December 14, 2012. The current certification is valid through May 31, 2022.

How is this Human Genome Sciences, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 49401010301. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
49401-103-01
11-Digit CMS (5-4-2)
49401-0103-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.